UA47832U - Способ замедления процессов старения кожи и омоложения - Google Patents
Способ замедления процессов старения кожи и омоложения Download PDFInfo
- Publication number
- UA47832U UA47832U UAU200909150U UAU200909150U UA47832U UA 47832 U UA47832 U UA 47832U UA U200909150 U UAU200909150 U UA U200909150U UA U200909150 U UAU200909150 U UA U200909150U UA 47832 U UA47832 U UA 47832U
- Authority
- UA
- Ukraine
- Prior art keywords
- skin
- hyaluronic acid
- processes
- aging
- microcirculation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract description 68
- 230000008569 process Effects 0.000 title abstract description 12
- 230000032683 aging Effects 0.000 title abstract description 10
- 230000003716 rejuvenation Effects 0.000 title abstract description 8
- 229920002674 hyaluronan Polymers 0.000 abstract description 24
- 229960003160 hyaluronic acid Drugs 0.000 abstract description 23
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract description 22
- 238000002360 preparation method Methods 0.000 abstract description 15
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract description 13
- 229940074404 sodium succinate Drugs 0.000 abstract description 10
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 4
- 239000008215 water for injection Substances 0.000 abstract description 2
- 239000008354 sodium chloride injection Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 54
- 230000000694 effects Effects 0.000 description 19
- 230000004089 microcirculation Effects 0.000 description 18
- 239000003814 drug Substances 0.000 description 16
- 210000001519 tissue Anatomy 0.000 description 15
- 229940079593 drug Drugs 0.000 description 14
- 230000037303 wrinkles Effects 0.000 description 13
- 206010033733 Papule Diseases 0.000 description 12
- 230000009759 skin aging Effects 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 229920001436 collagen Polymers 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 210000004207 dermis Anatomy 0.000 description 7
- 210000000707 wrist Anatomy 0.000 description 7
- 230000015572 biosynthetic process Effects 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 210000002950 fibroblast Anatomy 0.000 description 5
- 210000001061 forehead Anatomy 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 4
- 210000000744 eyelid Anatomy 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 239000001384 succinic acid Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 102000016942 Elastin Human genes 0.000 description 3
- 108010014258 Elastin Proteins 0.000 description 3
- 206010024264 Lethargy Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 229920002549 elastin Polymers 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000001243 protein synthesis Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000007665 sagging Methods 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010020112 Hirsutism Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000004098 cellular respiration Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 238000009499 grossing Methods 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 238000000520 microinjection Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000008756 pathogenetic mechanism Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000005641 tunneling Effects 0.000 description 2
- 230000002407 ATP formation Effects 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 108700016947 Bos taurus structural-GP Proteins 0.000 description 1
- 101100407073 Caenorhabditis elegans parp-1 gene Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027783 Moaning Diseases 0.000 description 1
- 101100353036 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pme-1 gene Proteins 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 206010040799 Skin atrophy Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000010455 autoregulation Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 1
- 229940099552 hyaluronan Drugs 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000001272 neurogenic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000037204 skin physiology Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 210000005070 sphincter Anatomy 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Способ замедления процессов старения кожи и омоложения включает интрадермальное введение препарата гиалуроновой кислоты. Вводят препарат, который дополнительно содержит сукцинат натрия, кислоту янтарную, натрия хлорид и воду для инъекций.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200909150U UA47832U (ru) | 2009-09-07 | 2009-09-07 | Способ замедления процессов старения кожи и омоложения |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU200909150U UA47832U (ru) | 2009-09-07 | 2009-09-07 | Способ замедления процессов старения кожи и омоложения |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA47832U true UA47832U (ru) | 2010-02-25 |
Family
ID=50693196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU200909150U UA47832U (ru) | 2009-09-07 | 2009-09-07 | Способ замедления процессов старения кожи и омоложения |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA47832U (ru) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2625548C1 (ru) * | 2015-04-29 | 2017-07-14 | Жанна Юрьевна Юсова | Способ коррекции возрастных изменений кожи лица |
| RU2663391C1 (ru) * | 2018-01-30 | 2018-08-03 | Игорь Николаевич Бондаренко | Способ эстетической коррекции мягких тканей лица |
-
2009
- 2009-09-07 UA UAU200909150U patent/UA47832U/ru unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2625548C1 (ru) * | 2015-04-29 | 2017-07-14 | Жанна Юрьевна Юсова | Способ коррекции возрастных изменений кожи лица |
| RU2663391C1 (ru) * | 2018-01-30 | 2018-08-03 | Игорь Николаевич Бондаренко | Способ эстетической коррекции мягких тканей лица |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Yagi et al. | Glycative stress and anti-aging: 7. Glycative stress and skin aging | |
| CN111110623A (zh) | 自体修复小小针营养液配方 | |
| RU2289417C1 (ru) | Способ биологического омоложения кожи | |
| WO2005036989A1 (ja) | ヒアルロン酸とデルマタン硫酸を含有する健康食品 | |
| RU2383341C2 (ru) | Способ омоложения кожи | |
| Levy et al. | Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone | |
| CN106344435A (zh) | 消除妊娠纹的护肤膏 | |
| UA47832U (ru) | Способ замедления процессов старения кожи и омоложения | |
| RU2571686C1 (ru) | Способ омоложения кожи лица у пациентов с анатомо-физиологическими особенностями лицевой части черепа | |
| ES2541177A2 (es) | Formulación cosmética de uso tópico con capacidad de regeneración dérmica, epidérmica y antiarrugas | |
| Maciuszek-Malinowska et al. | The effects of combined diamond microdermabrasion and a mixture of cosmetic acids on the condition of acne prone skin: a case report | |
| He et al. | Clinical Effect of Microneedle Injection Combined with Blood Transfusion in the Treatment of Severe Anemia Complicated with Vitiligo under Regenerative Medical Technology | |
| Matthews-Brzozowska et al. | Mesotherapy–a method of facial skin rejuvenation from an interdisciplinary perspective on improving facial aesthetics | |
| Nacopoulos | Use of platelet rich fibrin in facial aesthetics and rejuvenation | |
| RU2667130C1 (ru) | Хитозансодержащий гидрогель и способ косметического ухода за кожей с его использованием | |
| Saniee et al. | Consider of micro-current's effect to variation of facial wrinkle trend, randomized clinical trial study | |
| EP2253304A2 (en) | Nifedipine-based compositions for anti-wrinkle treatments | |
| Chernoff | A novel combination therapy in aesthetic and reconstructive surgery: sea salt, exfoliation, cavitating ultrasound, and high intensity multiwavelength LED treatment:(SaltFacial) | |
| Matthews‑Brzozowska et al. | CGF Harmony facial skin revitalization for a 40+ patient | |
| RU2742964C2 (ru) | Косметическая композиция | |
| RU2705202C1 (ru) | Космецевтический комплекс для ухода за кожей и способ его применения | |
| De Padova et al. | Biorevitalization and combination techniques | |
| KR20100102388A (ko) | 발 마사지 크림 조성물 | |
| RU2568589C1 (ru) | Способ коррекции эстетических и возрастных проблем кожи | |
| Svolacchia et al. | Off-label use of a medium-high molecular weight, isotonic and sterile hyaluronic acid in aesthetic medicine: cases report |